BSE filing, NSE: SUPRIYA. Summary written from the filing by ALFA Finder's alert engine.
Supriya Lifescience Ltd: key numbers
- Share price
- ₹847.30
- Market cap
- ₹6,819 Cr
- Revenue (annual)
- ₹827.9 Cr
- Net profit (annual)
- ₹209.1 Cr
- P/E (TTM)
- 34.4×Sector 48.7×
- Promoter holding
- 68.30%+0.00% QoQ
- FII holding
- 6.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Supriya Lifescience Ltd
All →Supriya Lifescience Board Meeting Date
Supriya Lifescience will hold a board meeting on 6 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results are declared.
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed a pending case was admitted by the Supreme Court. An interim order precludes coercive action against directors while the matter is sub judice.
Supriya Lifescience Other Announcement
Supriya Lifescience disclosed a CRISIL ESG rating of 65 in the Strong category. No financial or operational event accompanies the disclosure.
Supriya Lifescience Legal & Regulatory
Supriya Lifescience has filed a petition with the Supreme Court of India regarding ongoing judicial proceedings. The matter is currently sub judice and pending consideration.
Supriya Lifescience Annual General Meeting
Supriya Lifescience Limited conducted its 18th Annual General Meeting on September 24, 2026. All resolutions proposed in the meeting were passed with the requisite majority.
Supriya Lifescience Legal & Regulatory
Bombay High Court ordered provisional release of 200 kg Ketamine Hydrochloride consignment subject to ₹0.72 Crore deposit. Criminal and NDPS proceedings continue.
- Value
- ₹0.72 Cr
Other board meeting date announcements
All →Richa Info Systems Board Meeting Date
Richa Info Systems rescheduled its board meeting from 30 October to 6 November 2026 due to unavoidable circumstances. Agenda proposes fund raising through preferential or rights issue.
Signatureglobal (India) Board Meeting Date
Signatureglobal (India) has scheduled a board meeting on November 5, 2026, to consider unaudited standalone and consolidated results for Q2 and H1 FY2026-27. The trading window stays closed until November 7, 2026.
Mahasagar Travels Board Meeting Date
Mahasagar Travels will hold a board meeting on 5 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window opened 1 October 2026.
Sansera Engineering Board Meeting Date
Sansera Engineering will hold a board meeting on November 5, 2026 to approve unaudited results for the quarter ended September 30, 2026. The trading window for designated persons has been closed since October 1, 2026.
Contil India Board Meeting Date
Contil India will hold a board meeting on 6 November 2026 to consider unaudited standalone half-yearly results. Trading window closed 1 October to 14 November 2026.
GSB Finance Board Meeting Date
Coffers Finvest will hold a board meeting on 4 November 2026 to approve September quarter results. Trading window stays closed until 48 hours after results.